Follow
Jordi Silvestre Soto, Ph.D.
Jordi Silvestre Soto, Ph.D.
Senior Pharmacologist (Oryzon Genomics, S.A.); Associate Professor (UAB); Associate
Verified email at uoc.edu - Homepage
Title
Cited by
Cited by
Year
Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
JS Silvestre, J Prous
Methods and findings in experimental and clinical pharmacology 27 (5), 289-304, 2005
1592005
Acute effects of ketamine in the holeboard, the elevated‐plus maze, and the social interaction test in Wistar rats
JS Silvestre, R Nadal, M Pallares, N Ferre
Depression and anxiety 5 (1), 29-33, 1997
1331997
Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches.
A Camins, M Pallas, JS Silvestre
Methods and findings in experimental and clinical pharmacology 30 (1), 43-65, 2008
1252008
Pleiotropic effects of statins and related pharmacological experimental approaches.
M Alegret, JS Silvestre
Methods and findings in experimental and clinical pharmacology 28 (9), 627-656, 2006
1132006
Insulin analogues in the management of diabetes
M Vazquez-Carrera, JS Silvestre
Methods Find Exp Clin Pharmacol 26 (6), 445-461, 2004
742004
Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat
JS Silvestre, MF O'Neill, AG Fernández, JM Palacios
European journal of pharmacology 318 (2-3), 257-265, 1996
671996
Drug discovery targets: 5-HT6 receptor
S Davies, JS Silvestre, X Guitart
Drugs of the Future 30 (5), 2005
562005
Pagoclone-anxiolytic GABA-A/BZD site partial agonist
LA Sorbera, PA Leeson, J Silvestre, J Castaner
Drugs of the Future 26 (7), 651-657, 2001
532001
Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test
JS Silvestre, AG Fernández, JM Palacios
European journal of pharmacology 309 (3), 219-222, 1996
531996
Effects of rolipram on the elevated plus-maze test in rats: a preliminary study
JS Silvestre, AG Fernández, JM Palacios
Journal of psychopharmacology 13 (3), 274-277, 1999
491999
Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats
JS Silvestre, AG Fernández, JM Palacios
Pharmacology Biochemistry and Behavior 64 (1), 1-5, 1999
441999
Effects of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in rats
MA Pallares, RA Nadal, JS Silvestre, NS Ferre
Physiology & behavior 57 (2), 389-392, 1995
401995
Opposite effects of ethanol and ketamine in the elevated plus-maze test in Wistar rats undergoing a chronic oral voluntary consumption procedure
JS Silvestre, M Pallarés, R Nadal, N Ferré
Journal of Psychopharmacology 16 (4), 305-312, 2002
392002
Vilazodone hydrochloride
LA Sorbera, X Rabasseda, J Silvestre, J Castaner
Drugs of the Future 26 (3), 2001
372001
Acyl coenzyme A: cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs.
M Alegret, G Llaverias, JS Silvestre
Methods and findings in experimental and clinical pharmacology 26 (7), 563-586, 2004
362004
Etoricoxib
LA Sorbera, RM Castaner, J Silvestre, J Castaner
Drugs of the Future 26 (4), 2001
362001
Eplerenone
X Rabasseda, J Silvestre, J Castaner
Drugs of the Future 24 (5), 1999
351999
Aprepitant and L-758298: antiemetic, antidepressant, tachykinin NK1 antagonist
LA Sorbera, J Castaner, M Bayes, J Silvestre
Drugs of the Future 27 (3), 211-222, 2002
342002
Comparative evaluation of hERG potassium channel blockade by antipsychotics.
JS Silvestre, JR Prous
Methods and findings in experimental and clinical pharmacology 29 (7), 457-466, 2007
332007
Experimental approaches to study PPAR gamma agonists as antidiabetic drugs
M Vazquez, JS Silvestre, JR Prous
Methods Find Exp Clin Pharmacol 24 (8), 515-523, 2002
322002
The system can't perform the operation now. Try again later.
Articles 1–20